Comparison

Bempedoic acid European Partner

Item no. TMO-T3625-2mg
Manufacturer TargetMol
CASRN 738606-46-7
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Nikolic D, et al. Atherosclerosis. 2014, 237(2):705-710.
Smiles CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias ETC1002,ESP-55016,ETC 1002,ETC-1002
Shipping Condition Cool pack
Available
Manufacturer - Targets
AMPK|||ATP Citrate Lyase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
344.49
Description
Bempedoic acid (ETC1002) is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies. Bempedoic acid(ETC1002) is absorbed rapidly in the small intestine and enters the liver through cell surface receptors different from those transporters that selectively take up statins. Bempedoic acid(ETC1002) is a regulator of lipid and carbohydrate metabolism.
Pathways
Chromatin/Epigenetic|||PI3K/Akt/mTOR signaling|||Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close